Transplantation Industry Overview

The global transplantation market size was estimated at USD 15.0 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030.

Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the market growth. Organ failure usually occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. Demand for tissue and organ transplantation, mainly kidney, heart, liver, and lungs, is very high globally. Unhealthy dietary habits, alcohol consumption, lack of exercise, and drug abuse are some leading causes of organ failure. Thus, demand for transplantation products is expected to rise soon.

Gather more insights about the market drivers, restrains and growth of the Transplantation Market

After a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases as their immunity is weakened. This can be attributed to the decline in transplantation numbers in many countries amid the COVID-19 situation. Moreover, the shortage of resources such as primary protective equipment, ICU, and blood products during the pandemic has contributed to the sharp fall in the market’s revenue in 2020.   

The global increase in the demand for organs for transplant can be attributed to an increase in the incidence of acute diseases, which in turn results in an increase in the number of organ failures. For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, where kidney transplants or dialysis are the only treatment options to keep a patient alive. According to the U.S. Department of Health & Human Services, there were around 122,913 patients in the U.S. waiting to receive organs for transplant in 2019. Thus, there are high demand for advanced transplantation products for the treatment of organ failure. To manage such issues, in March 2023, U.S. government department of Health Resources and Services Administration (HRSA) took an initiative regarding transplantation network and organ procurement modernization.  This idea focuses on the release of new organ donor and transplant data.

Some of the major driving factors impacting the market include the introduction of technologically advanced products and an increasing number of tissue banks. However, some of the factors such as the shortage of organ donors for transplantation procedures are expected to restrain the market growth. There is a huge gap between the demand and supply of organs for organ failure treatment. According to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients waiting for kidney transplants in the U.S. However, only 23,401 kidney transplant procedures were performed in 2019. Lack of awareness for organ donation and religious & customary beliefs prevent a large number of people from donating. Thus, the shortage of organs for the treatment of organ failure is expected to adversely affect the market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

  • The global ophthalmic viscosurgical devices market size was valued at USD 410.2 million in 2023 and is projected to grow at a CAGR of 6.3% from 2024 to 2030.
  • The global 3D bioprinting market size was valued at USD 2.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030.

Transplantation Market Segmentation

Grand View Research has segmented the global transplantation market on product, application, end-use, and region:

Transplantation Product Outlook (Revenue, USD Million; 2018 - 2030)

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solution

Transplantation Application Outlook (Revenue, USD Million; 2018 - 2030)

  • Organ Transplantation
  • Tissue Transplantation

Transplantation End Use Outlook (Revenue, USD Million; 2018 - 2030)

  • Hospitals
  • Transplant Centers
  • Others

Transplantation Regional Outlook (Revenue, USD Million; 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Key Companies profiled:

  • AbbVie, Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • 21st Century Medicine
  • BioLifeSolutions, Inc
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals

Key Transplantation Company Insights

The market is highly fragmented with the presence of many large, small, and medium-scale vendors. The leading players in the industry are Zimmer Biomet; Medtronic; Stryker Corporation. These players are involved in launching new products, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, In April 2023, a team of surgeons in Spain performed world’s first robotic lung transplant, a novel lung transplant method that uses robot labelled as Da Vinci.

Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting, have led to high demand for transplant products. This 3D bioprinting can be used to regenerate tissues and organs. For instance, in September 2020 Israel-based CollPlant Biotechnologies and United therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant.

Order a free sample PDF of the Transplantation Market Intelligence Study, published by Grand View Research.